Podophyllotoxin
Showing 26 - 50 of 117
Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United
Recruiting
- Acute Adult T-Cell Leukemia/Lymphoma
- +3 more
- Cyclophosphamide
- +5 more
-
Atlanta, Georgia
- +13 more
Jan 26, 2023
Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II
Active, not recruiting
- Aggressive Non-Hodgkin Lymphoma
- +13 more
- Cyclophosphamide
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 18, 2022
Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,
Not yet recruiting
- Bilateral Retinoblastoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Aug 17, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Seattle
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +4 more
- Cisplatin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 13, 2022
Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,
Recruiting
- Burkitt Lymphoma
- +2 more
- Rituximab and Hyaluronidase Human
- +8 more
-
Kampala, UgandaUCI-Fred Hutch Cancer Centre
Mar 9, 2022
Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)
Not yet recruiting
- Recurrent Classic Hodgkin Lymphoma
- Refractory Classic Hodgkin Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- +13 more
- (no location specified)
Feb 2, 2023
Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small
Recruiting
- Desmoplastic Small Round Cell Tumor
- +11 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jun 26, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Carboplatin
- +5 more
-
Jacksonville, Florida
- +11 more
Jan 12, 2023
Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)
Completed
- Mantle Cell Lymphoma
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +2 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Cyclophosphamide
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 18, 2022
Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma
Recruiting
- Bladder Small Cell Neuroendocrine Carcinoma
- +16 more
- Carboplatin
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Carboplatin
- +4 more
-
Duarte, California
- +3 more
Oct 24, 2022
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Trial
Recruiting
- Stage II Non-Small Cell Lung Cancer AJCC v7
- +5 more
- Carboplatin
- +9 more
-
Jacksonville, Florida
- +29 more
Dec 15, 2022
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
DLBCL Unclassifiable Trial in Houston (Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide)
Active, not recruiting
- Diffuse Large B-Cell Lymphoma Unclassifiable
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Feb 23, 2022
Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,
Active, not recruiting
- Ganglioneuroblastoma
- High Risk Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Los Angeles, California
- +9 more
Sep 1, 2022
Acute Myeloid Leukemia, Minimal Residual Disease Negativity Trial in Seattle (procedure, drug, other)
Withdrawn
- Acute Myeloid Leukemia
- Minimal Residual Disease Negativity
- Autologous Hematopoietic Stem Cell Transplantation
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 27, 2021
Extensive Stage Lung Small Cell Carcinoma Trial in Duarte (Atezolizumab, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Atezolizumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
DLBCL Unclassifiable, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial in Duarte,
Recruiting
- Diffuse Large B-Cell Lymphoma Unclassifiable
- +6 more
- Carboplatin
- +4 more
-
Duarte, California
- +1 more
Oct 1, 2021
Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in United States (biological,
Recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Atezolizumab
- +7 more
-
Jonesboro, Arkansas
- +35 more
Aug 12, 2022
Stage IIIA NSCLC Trial in Philadelphia (radiation, drug, procedure)
Completed
- Stage IIIA Non-small Cell Lung Cancer
- proton beam radiation therapy
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Apr 23, 2021